logo
OLS Enterprise^ - DL Stock (E15) - Price and Fundamental Data | DZHI - DZH International
OLS Enterprise^ - DL (E15)

Company Info and Fundamentals

Principal Activities
OLS Enterprise Limited is a Life Sciences company, engaged in the research, development and commercialisation of cutting-edge technologies to improve and enhance the Quality of Life.

Its current focus includes transdermal drug delivery systems and specialised cosmetic products for the pharmaceutical and cosmeceutical industries. Transcu's transdermal drug delivery technologies allow the local and systemic delivery of drugs through the skin into the body. This innovative, pain-free, non-invasive method can be customised for a wide variety of medical, pharmaceutical and cosmeceutical applications, as an alternative to injections, oral pills and other drug delivery methods such as transmucosal and inhalation.

As a knowledge-based company, it holds patents for three device inventions and has over 500 live filings for patents applications and formulations worldwide.

The company has already succeeded in generating revenues from licensing its proprietary technologies to strategic business partners and anticipates sustainable revenues from manufacturing, distribution and sale of end-products using its proprietary technologies.
Profile
Full NameOLS Enterprise LimitedStock NoE15
ExchangeSingapore Exchange (SGX)BoardMain board
ISIN CodeYear-End31-Mar
Exchange SectorServicesSub Sector1
Par Value (USD)0.0000Issued Shares (Mil)9528.6420
Paid-Up Cap. (SGD Mil)733.4320Market Capitalization (Mil)9.5286
Technical
Share Price (SGD)
Current Price0.00
Previous Close0.00
Week High0.00
Week Low0.00
Month High0.00
Month Low0.00
52-week High0.01
52-week Low0.00
Share Price Performance(%)
MTD change-100.0000
YTD change-100.0000
Volume
Today Volume('000)0
100-day Average Daily Volume ('000)0.00
Technical Indicators-A shapshot
RSI43.80
100-day Moving average0.00
Ratio (Daily)
Dividend Yield0.00
P/E ratio1.11



Financial Ratios
2014
CurrencyUSD
Exchange Rate*-
Profitability Ratio
Return on Equity-56.760
Return on Revenue0.000
Liquidity Ratio
Return on Equity0.280
Return on Revenue0.280
Gross Eps (cents) *0.090
Dividend (cents) *0.000
Net tangible asset-22.802
Price to cash flow ratio0.000
Cash for per share-0.040
Price to book ratio0.000
* Calculation is based on the specific Currency Exchange Rate
Financial Ratios
2015 Q22015 Q12014 Q42014 Q3
CurrencyUSD
Exchange Rate*----
Profitability Ratio
Return on Equity-6.17411.423-56.760694.978
Return on Revenue0.0000.0000.000-814.843
Liquidity Ratio
Return on Equity0.6520.2160.2800.261
Return on Revenue0.6520.2160.2800.204
Gross Eps (cents) *0.0100.0000.090-0.700
Dividend (cents) *0.0000.0000.0000.000
Net tangible asset-1.690-25.509-22.802-6.466
Price to cash flow ratio0.0000.0000.0000.000
Cash for per share-0.332-0.007-0.081-0.044
Price to book ratio0.0000.0000.0000.000
* Calculation is based on the specific Currency Exchange Rate
No Data Avaliable